Capecitabine (Xeloda) is an antimetabolite chemotherapy medication. It's used to treat many different types of cancer, including colorectal cancer, breast cancer, and pancreatic cancer. Capecitabine (Xeloda) prevents cancer cells from spreading by interfering with the genetic material. This medication is taken by mouth, typically twice daily, within 30 minutes of a meal. Some of the more common side effects of capecitabine (Xeloda) include hand-and-foot syndrome (a skin reaction) and serious diarrhea.
After the tumor has been surgically removed
Advanced or metastatic colon cancer
Together with radiation before or after surgery
Advanced or metastatic rectal cancer
Metastatic breast cancer
Metastatic gastric, esophageal, or gastroesophageal junction (EGJ) cancer
Pancreatic cancer, after the tumor has been surgically removed
Capecitabine (Xeloda) is an antimetabolite chemotherapy. Once it gets inside the body, capecitabine (Xeloda) is converted into fluorouracil, which is the active form of this medication. It prevents cells from making the genetic material needed to grow and multiply. Because cancer cells tend to grow much faster than healthy cells, fluorouracil ends up affecting cancer cells more. As a result, cancer cells can’t grow and spread as well.
Source:Â DailyMed
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur:
More common
Abdominal or stomach pain
loss of fingerprints
numbness, pain, tingling, or other unusual sensations in the palms of the hands or bottoms of the feet
pain, blistering, peeling, redness, or swelling of the palms of the hands or bottoms of the feet
pain, redness, swelling, sores, or ulcers in your mouth or on your lips
unusual tiredness or weakness
vomiting
Less common or rare
Abdominal or stomach cramping or pain (severe)
agitation
back pain
bleeding and bruising
bleeding gums
blood in the urine or stools
bloody nose
bloody or black, tarry stools
blurred vision
burning, dry, or itching eyes
chills
clumsiness or unsteadiness
collapse
coma
confusion
convulsions
cough or hoarseness (accompanied by fever or chills)
cough producing mucus
coughing or spitting up blood
dark urine
decreased frequency or amount of urine
difficulty with breathing
difficulty with swallowing or pain in the back of throat or chest when swallowing
discharge from the eyes
drowsiness
excessive tearing
extra heartbeats
eye redness, irritation, or pain
fainting
fast or irregular heartbeat
fever or chills
flu-like symptoms
hallucinations
headache, sudden and severe
heavier menstrual periods
high fever
hot, red skin on the feet or legs
inability to speak
increased menstrual flow or vaginal bleeding
increased thirst
irritability
itching in the genital or other skin areas
lightheadedness
light-colored stools
loss of consciousness
lower back or side pain (accompanied by fever or chills)
muscle aches or cramps
nosebleeds
numbness or tingling in the hands, feet, or lips
painful or difficult urination (accompanied by fever or chills)
painful, swollen feet or legs
pain, tenderness, or swelling in the upper abdominal or stomach area
pale skin
paralysis
pinpoint red spots on the skin
problems with coordination
prolonged bleeding from cuts
rapid, shallow breathing
red or dark brown urine
redness, pain, or swelling of the eye, eyelid, or inner lining of the eyelid
scaling
seizures
severe constipation
skin rash or itching
slow or irregular heartbeat
slurred speech
sneezing, sore throat, or stuffy nose
sores, ulcers, or white spots on the lips or in the mouth
stiff neck
stomach bloating, burning, or cramping
swelling of the face, fingers, feet, or lower legs
swelling of the lymph nodes
swollen glands
temporary blindness
tiredness or weakness
trouble with speaking
troubled breathing or tightness in the chest
unexplained nosebleeds
unusual bleeding or bruising
unusual lump or swelling in the chest
vomiting blood or material that looks like coffee grounds
weakness in the arm or leg on one side of the body, sudden and severe
weight gain or loss
white patches in the mouth or throat or on the tongue
white patches with diaper rash
yellow eyes or skin
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Less common
Burning, crawling, itching, numbness, prickling, “pins and needles”, or tingling feelings
changes or discoloration in the fingernails or toenails
difficulty with moving
discouragement
headache
increased sensitivity of the skin to sunlight
pain and redness of the skin at the place of x-ray treatment
pain in the joints or limbs
red, sore eyes
sunken eyes
thirst
trouble sleeping
weakness
wrinkled skin
Rare
Bone pain
change in color of treated skin
difficulty with walking
discouragement
feeling of constant movement of self or surroundings
feeling sad or empty
full or bloated feeling or pressure in the stomach
general feeling of discomfort or illness
hot flushes
impaired balance
increased sweating
joint pain
lack of appetite
loss of interest or pleasure
muscle weakness
noisy breathing
pain in the rectum
pain, swelling, or redness in the joints
passing less gas
rough, scratchy sound to voice
sensation of spinning
shakiness in the legs, arms, hands, or feet
shivering
sores on the skin
swelling of abdominal or stomach area
tremor or shaking of the hands or feet
trouble concentrating
voice changes
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
Taken by mouth
Doesn't cause as much hair loss as similar chemotherapies
Available as a lower-cost generic medication
Taken twice daily
Need to take within 30 minutes after a meal
Must use birth control while taking since it can cause harm to an unborn baby
Create a calendar or use an app on your phone to keep track of when you should take your medications. Capecitabine (Xeloda) and many chemotherapy medications are taken in cycles to lower the risk of side effects.
Swallow the capecitabine (Xeloda) tablets whole with water within 30 minutes after a meal.
Don't crush or cut the capecitabine (Xeloda) tablets. The powder from crushed tablets can cause problems to you or other people who live in your house.
Diarrhea is a common side effect of capecitabine (Xeloda). Contact your provider if you have diarrhea. If your symptoms are mild, they might recommend you take an over-the-counter medication, such as loperamide (Imodium) to help. Seek medical help right away if you experience severe bloody diarrhea, stomach pain, and fever.
Capecitabine (Xeloda) sometimes causes a side effect called hand-foot syndrome (HFS), which is a skin condition on the palms of your hands and soles of your feet. To help prevent HFS, avoid hot showers and washing your hands with hot water. Wear comfortable, loose-fitting shoes and apply lotion to your hands and feet every day.
Make sure to stay hydrated by drinking plenty of fluids throughout the day while taking capecitabine (Xeloda). Dehydration can lead to kidney problems, which can be serious.
Capecitabine (Xeloda) can harm an unborn baby. If you’re a female able to have babies, you should use effective birth control while taking capecitabine (Xeloda) and for 6 months after the last dose. If you’re a male who is sexually active with a female able to have babies, you should use effective birth control, such as condoms, while taking capecitabine (Xeloda) and for 3 months after the last dose.
If you're also taking warfarin (Coumadin), let your warfarin (Coumadin) clinic know you're going to start taking capecitabine (Xeloda). This medication can interact with your blood thinner and cause you to bleed more easily. Because of this, your clinic might want to monitor your warfarin (Coumadin) therapy more closely.
We don’t know if capecitabine (Xeloda) passes into human milk. But it does, there's a chance that it can harm a nursing infant. Because of this, your provider will ask you to avoid breastfeed while taking capecitabine (Xeloda) and for 1 week after the last dose.
Capecitabine (Xeloda) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Risk factors: Age 60 years or older
Taking capecitabine (Xeloda) with the blood thinner warfarin (Coumadin) can raise your risk of serious and even sometimes life-threatening bleeding. It's thought that capecitabine (Xeloda) can affect how well warfarin (Coumadin) gets broken down in your body, which raises warfarin (Coumadin) levels in your body and your risk of bleeding. If you're taking warfarin (Coumadin), let your warfarin (Coumadin) clinic know about your chemotherapy regimen and when you're taking capecitabine (Xeloda). You'll need to follow up with your clinic more often. That way, they can monitor your warfarin (Coumadin) treatment more closely and adjust your blood thinner dose to lower your risk of serious bleeds.
Capecitabine (Xeloda) can cause diarrhea, which can be serious and lead to dehydration. For milder cases, your provider might recommend anti-diarrheal medications, like loperamide (Imodium A-D). More severe cases have occurred within the first month of taking capecitabine (Xeloda). Make sure to monitor your bowel movements during treatment. Contact your care team or get medical help right away if you have a large increase in stools (4 or more episodes) per day, have diarrhea during the night, or notice blood in your stools along with severe stomach pain and fever. Your provider might ask you to stop taking capecitabine (Xeloda) until your diarrhea gets better.
Risk factors: History of heart disease
Heart problems have occurred in some people taking capecitabine (Xeloda). These problems include heart attack, chest pain, abnormal heart rhythms, and heart failure. Your risk might be higher if you have a history of heart disease. Let your oncologist (cancer specialist) know your medical history so they can monitor you closer if needed.
Risk factors: History of kidney problems | Taking other medications that can cause kidney problems | Nausea, vomiting, or diarrhea | Anorexia or loss of appetite
Capecitabine (Xeloda) can cause dehydration, which can lead to severe kidney failure. Common side effects of this medication include vomiting, diarrhea, and loss of appetite, which can lead to dehydration. Dehydration can also happen when you don't drink enough fluids. Make sure you let your care team know about any side effects that you experience while taking this medication. They can adjust your dose and make sure you're hydrated.
Capecitabine (Xeloda) commonly causes a skin reaction called hand-and-foot syndrome. Most people who experience this do so within months of starting capecitabine (Xeloda). It might start as mild tingling, numbness, or painless swelling or redness in your hands and feet. But if you notice that it becomes painful or have blisters in your hands or feet, and it starts to interfere with your daily activities, let your care team know. Your provider might ask you to pause capecitabine (Xeloda) or take a lower dose until your symptoms resolve.
Capecitabine (Xeloda) can also cause rare but serious skin reactions, such as Stevens-Johnson Syndrome and toxic epidermal necrolysis (TEN). Let your provider know right away if you experience fever, rash, blisters after starting treatment.
Risk factors: taking capecitabine (Xeloda) with other chemotherapy medications
Though not common, taking capecitabine (Xeloda) can cause your blood cell counts to drop and put you at higher risk for conditions like infections and serious bleed. Your provider will check your blood cell counts before each cycle. If your blood counts are too low, your provider might make adjustments to your dose or pause your treatment until they recover.
Capecitabine (Xeloda) hasn’t been studied in human pregnancy, but based on animal studies and the way the medication works, it could harm an unborn baby. If you’re a female able to become pregnant, you should use effective birth control while taking capecitabine (Xeloda) and for 6 months after the last dose. If you’re a male who is sexually active with a female who can become pregnant, you should use effective birth control, such as condoms, while taking capecitabine (Xeloda) and for 3 months after the last dose.
Before starting capecitabine (Xeloda), your provider might test you for a rare genetic condition called dihydropyrimidine dehydrogenase (DPD) deficiency. People with this condition might not be able to take capecitabine (Xeloda) or need to take a lower dose because they’re at higher risk for a severe toxicity reaction with symptoms such as mouth sores, diarrhea, and nausea.
Your provider will calculate your dose based on your body surface area (BSA), which takes into account your height and weight. The dose and duration of therapy also depends on what type of cancer you’re being treated for, and what other anticancer medications or treatments (e.g., radiation) you’re receiving.
The typical dose ranges between 625 mg/m2 - 1250 mg/m2 by mouth twice a day.
If you’re receiving radiation, you’ll usually take capecitabine (Xeloda) during radiation treatment, which can last several weeks.
If you’re not receiving radiation, capecitabine (Xeloda) is commonly taken for 2 weeks out of every 3-week treatment cycle.
Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.
Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Hypersensitivity to fluorouracil
After the tumor has been surgically removed
Advanced or metastatic colon cancer
Together with radiation before or after surgery
Advanced or metastatic rectal cancer
Metastatic breast cancer
Metastatic gastric, esophageal, or gastroesophageal junction (EGJ) cancer
Pancreatic cancer, after the tumor has been surgically removed
Locally advanced or metastatic non-small cell lung cancer (NSCLC), used with cisplatin
Advanced ovarian cancer that’s come back at least 6 months after platinum-based chemotherapy, used with carboplatin (Paraplatin)
Metastatic breast cancer after anthracycline-based therapy hasn’t worked, used with paclitaxel
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Braghiroli, C. S., et al. (2017). Do you know this syndrome? Hand-foot syndrome. Anais Brasileiros de Dermatologia.
Genentech, Inc. (2023). Xeloda- capecitabine tablet, film coated [package insert]. DailyMed.
Kwakman, J. J. M., et al. (2020). Management of cytotoxic chemotherapy-induced hand-foot syndrome. Oncology Reviews.
Ly, R. C., et al. (2020). Severe capecitabine toxicity associated with a rare DPYD variant identified through whole-genome sequencing. Journal of Clinical Oncology Precision Oncology.
MedlinePlus. (2015). Dihydropyrimidine dehydrogenase deficiency.
National Cancer Institute. (2019). Radiation therapy to treat cancer.
National Cancer Institute. (2022). Eating hints: Before, during, and after cancer treatment.
National Cancer Institute. (2023). Capecitabine.
National Cancer Institute. (2024). Pancreatic cancer treatment (PDQ®)–Patient version.
National Comprehensive Cancer Network. (2023). Pancreatic cancer.
National Comprehensive Cancer Network. (2023). Stomach cancer.
National Comprehensive Cancer Network. (2024). Colon cancer.
National Comprehensive Cancer Network. (2024). Esophageal cancer.
National Comprehensive Cancer Network. (2024). Metastatic breast cancer.
National Comprehensive Cancer Network. (2024). Rectal cancer.
Reigner, B., et al. (2001). Clinical pharmacokinetics of capecitabine. Clinical Pharmacokinetics.
West, H. J., et al. (2017). Chemotherapy-induced hair loss (alopecia). Journal of the American Medical Association Oncology.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.